IMUNON CEO Dr. Corinne Le Goff to Participate in a Panel Discussion on Pandemic Preparedness at the United Nations
LAWRENCEVILLE, N.J., Oct. 19, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage biotechnology company focused on harnessing the power of the immune system against cancer and infectious diseases, announces that Dr. Corinne Le Goff, IMUNON’s President and Chief Executive Officer, will be participating in a pandemic preparedness panel at the United Nations in New York City on Thursday, October 19, 2023. Titled “A Tale of Two Pandemics: Lessons from the 1889 & 2019 Pandemics – Insights for Pandemic Preparedness,” the program is presented by the Foreign Policy Association, WBB Securities and UNITAR.
- Titled “A Tale of Two Pandemics: Lessons from the 1889 & 2019 Pandemics – Insights for Pandemic Preparedness,” the program is presented by the Foreign Policy Association, WBB Securities and UNITAR.
- Le Goff will discuss the development of the Covid-19 mRNA vaccine and IMUNON’s development of a DNA-based vaccine platform using the company’s PlaCCine modality.
- The moderator is Dr. Richard Marfuggi, M.D., D.M.H., Medical Ethicist, Medical Historian and Medical Director of the WBB Research Institute.
- Through its balanced, nonpartisan publications and programs, FPA encourages citizens to participate in the foreign policy process.